Format

Send to

Choose Destination
Skin Therapy Lett. 2014 Nov-Dec;19(6):5-7.

5% Minoxidil: treatment for female pattern hair loss.

Author information

1
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Mediprobe Research Inc., London, ON, Canada.
2
Mediprobe Research Inc., London, ON, Canada.

Abstract

Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. While 5% minoxidil foam has been approved for men since 2006, Health Canada and the FDA only approved 5% minoxidil foam for female pattern hair loss (FPHL) in 2014. Recent Phase III clinical trials demonstrated the efficacy of once daily 5% minoxidil foam for treatment of FPHL, where a significant change from baseline in the target area hair count was observed compared to placebo. Similar changes in hair count for 5% foam and twice daily 2% minoxidil solution established noninferiority of the 5% foam formulation. Five percent minoxidil foam provides an additional option for women with FPHL and will soon be available in Canada.

PMID:
25807073
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Skin Therapy Letter
Loading ...
Support Center